View in EDS HTML Full Text PDF Full Text

CAR T cell-induced interferon gamma enhances MHC class I expression and sensitizes neuroblastoma to TCR-engineered T cell therapy.

Saved in:
Bibliographic Details
Title: CAR T cell-induced interferon gamma enhances MHC class I expression and sensitizes neuroblastoma to TCR-engineered T cell therapy.
Authors: Vitali A; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany., Padlo J; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany., Caramel C; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany., Andersch L; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany.; German Cancer Consortium (DKTK), Partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Hartmann LM; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies, Berlin, Germany., Kath J; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies, Berlin, Germany., Grunewald L; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany., Schwiebert S; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany., Winkler A; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany., Talalai E; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany., Biereder T; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany., Wienke J; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Department of Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands., Launspach M; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany.; German Cancer Consortium (DKTK), Partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies, Berlin, Germany., Delebinski C; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany., Kern A; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany., Astrahantseff K; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany., Wagner DL; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies, Berlin, Germany., Willimsky G; German Cancer Consortium (DKTK), Partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute of Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Tumor Immunology, Berlin, Germany., Eggert A; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany.; University Hospital Essen, Essen, Germany., Blankenstein T; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Tumor Immunology, Berlin, Germany., Anders K; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany., Künkele A; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany.; German Cancer Consortium (DKTK), Partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Source: Frontiers in immunology [Front Immunol] 2026 Sep 18; Vol. 17, pp. 1901504. Date of Electronic Publication: 2026 Sep 18 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42827984
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CAR T cell-induced interferon gamma enhances MHC class I expression and sensitizes neuroblastoma to TCR-engineered T cell therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Vitali+A%22">Vitali A</searchLink>; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Padlo+J%22">Padlo J</searchLink>; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Caramel+C%22">Caramel C</searchLink>; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Andersch+L%22">Andersch L</searchLink>; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany.; German Cancer Consortium (DKTK), Partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Hartmann+LM%22">Hartmann LM</searchLink>; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Kath+J%22">Kath J</searchLink>; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Grunewald+L%22">Grunewald L</searchLink>; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Schwiebert+S%22">Schwiebert S</searchLink>; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Winkler+A%22">Winkler A</searchLink>; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Talalai+E%22">Talalai E</searchLink>; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Biereder+T%22">Biereder T</searchLink>; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Wienke+J%22">Wienke J</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Molenaar+JJ%22">Molenaar JJ</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Department of Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Launspach+M%22">Launspach M</searchLink>; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany.; German Cancer Consortium (DKTK), Partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Delebinski+C%22">Delebinski C</searchLink>; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Kern+A%22">Kern A</searchLink>; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Astrahantseff+K%22">Astrahantseff K</searchLink>; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Wagner+DL%22">Wagner DL</searchLink>; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Willimsky+G%22">Willimsky G</searchLink>; German Cancer Consortium (DKTK), Partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute of Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Tumor Immunology, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Eggert+A%22">Eggert A</searchLink>; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany.; University Hospital Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Blankenstein+T%22">Blankenstein T</searchLink>; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Tumor Immunology, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Anders+K%22">Anders K</searchLink>; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Künkele+A%22">Künkele A</searchLink>; Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Paediatric Oncology and Haematology, Berlin, Germany.; German Cancer Consortium (DKTK), Partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2026 Sep 18; Vol. 17, pp. 1901504. <i>Date of Electronic Publication: </i>2026 Sep 18 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42827984
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2026.1901504
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1901504
    Titles:
      – TitleFull: CAR T cell-induced interferon gamma enhances MHC class I expression and sensitizes neuroblastoma to TCR-engineered T cell therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Vitali A
      – PersonEntity:
          Name:
            NameFull: Padlo J
      – PersonEntity:
          Name:
            NameFull: Caramel C
      – PersonEntity:
          Name:
            NameFull: Andersch L
      – PersonEntity:
          Name:
            NameFull: Hartmann LM
      – PersonEntity:
          Name:
            NameFull: Kath J
      – PersonEntity:
          Name:
            NameFull: Grunewald L
      – PersonEntity:
          Name:
            NameFull: Schwiebert S
      – PersonEntity:
          Name:
            NameFull: Winkler A
      – PersonEntity:
          Name:
            NameFull: Talalai E
      – PersonEntity:
          Name:
            NameFull: Biereder T
      – PersonEntity:
          Name:
            NameFull: Wienke J
      – PersonEntity:
          Name:
            NameFull: Molenaar JJ
      – PersonEntity:
          Name:
            NameFull: Launspach M
      – PersonEntity:
          Name:
            NameFull: Delebinski C
      – PersonEntity:
          Name:
            NameFull: Kern A
      – PersonEntity:
          Name:
            NameFull: Astrahantseff K
      – PersonEntity:
          Name:
            NameFull: Wagner DL
      – PersonEntity:
          Name:
            NameFull: Willimsky G
      – PersonEntity:
          Name:
            NameFull: Eggert A
      – PersonEntity:
          Name:
            NameFull: Blankenstein T
      – PersonEntity:
          Name:
            NameFull: Anders K
      – PersonEntity:
          Name:
            NameFull: Künkele A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 09
              Text: 2026 Sep 18
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1